Surgalign Holdings (Surgalign Holdings) GF Value : $3.91 (As of Apr. 27, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Surgalign Holdings GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-04-27), Surgalign Holdings's share price is $0.018. Surgalign Holdings's GF Value is $3.91. Therefore, Surgalign Holdings's Price-to-GF-Value for today is 0.00.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Surgalign Holdings is Data Out of Date, Use Caution.

Surgalign Holdings (OTCPK:SRGAQ) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Surgalign Holdings's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	0.018	/	3.91
	=	0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Surgalign Holdings GF Value Related Terms

Thank you for viewing the detailed overview of Surgalign Holdings's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Surgalign Holdings (Surgalign Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surgalign Holdings Inc (OTCPK:SRGAQ) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

520 Lake Cook Road, Suite 315, Deerfield, IL, USA, 60015

Website

https://www.surgalign.com

Surgalign Holdings Inc is a global medical technology company advancing the science of spine care, focused on delivering innovative solutions that drive superior clinical and economic outcomes. The company continues to invest in clinically validated innovation to deliver the Best surgical outcomes and improve patient's lives. It markets products throughout the United States and in more than 50 countries worldwide through an expanding network of top independent distributors. The U.S. market accounts for the vast majority of revenue. It has commercial and design centers in San Diego, California, and Wurmlingen, Germany.

Executives

Elizabeth A. Lapuma	director	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Jill Kathleen Frizzley	director	P.O. BOX 1541, ONE BLUE HILL PLAZA, PEARL RIVER NY 10965
Paolo Amoruso	officer: Chief Legal Officer	C/O HYPERDYNAMICS CORPORATION, 12012 WICKCHESTER LANE, SUITE 475, HOUSTON TX 77079
David Lyle	officer: Chief Financial Officer	6290 SEQUENCE DRIVE, SAN DIEGO CA 92121
Marc E. Mackey	officer: EVP, Digital Surgery	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Terry M. Rich	officer: President, Global Spine	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
William Scott Durall	officer: Chief Commercial Officer	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Christopher Thunander	officer: Chief Accounting Officer	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Thomas Mceachin	director	11621 RESEARCH CIRCLE, ALACHUA FL 32615
Nicholas J Valeriani	director	C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Sheryl L Conley	director	C/O NEURONETICS, INC., 3222 PHOENIXVILLE PIKE, MALVERN PA 19355
Enrico Sangiorgio	officer: EVP, International	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Stuart F. Simpson	director	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Pawel Lewicki	director	296 WOODWARD BLVD., TULSA OK 74114
Jeffrey C Lightcap	director	152 W 57TH STREET 43RD FLOOR, NEW YORK NY 10019